BusinessAgile Therapeutics Reports Third Quarter 2016 Financial Results and Announces Completion of Subject Visits for Twirla® Phase 3 SECURE Clinical TrialBy Nasdaq OMXNov 7, 2016, 9:10 PM UTC
BusinessEQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Mylan N.V. - MYLBy Nasdaq OMXNov 2, 2016, 8:54 PM UTC
